European Medicines Agency (EMA) | What's new 한국어 팔로우 고아 지정: resecabtagene autoleucel 특발성 염증성 근육병증 치료, 2025/07/18 긍정 Orphan designation: resecabtagene autoleucel Treatment of idiopathic inflammatory myopathy, 18/07/2025 Positive ema.europa.eu
